The cost of suspected and confirmed bacterial meningitis cases treated at Jimma University Medical Center, Ethiopia

Abstract

BACKGROUND: Infections of the central nervous system (CNS) such as meningitis or encephalitis can be caused by myriad of microorganisms and may be life-threatening. In Ethiopia, it is an important cause of premature death and disability, being the 9th most common cause of years of life lost and loss of disability adjusted life years. The objective of this study was to estimate the cost of suspected and confirmed bacterial meningitis among inpatient managed patients at JUMC.METHODS: A facility-based cross-sectional study was conducted from July 28 to September 12, 2018. A semi-structured questionnaire was used in this study. Checklists were used to collect the types of laboratory tests performed and prescribed medications. This cost of illness study was conducted from the patient perspectives. We employed a micro-costing bottom-up approach to estimate the direct cost of meningitis. The humancapital approach was used for estimating wages lost.RESULT: Among total patients admitted and treated in JUMC, higher proportions (69.8%) were suspected bacterial meningitis but have been treated as confirmed cases. Total median costs for both suspected and confirmed bacterial meningitis patients were estimated to be ETB 98,812.32 (US $ 3,593.2; IQR 1,303.0 to 5,734.0). Total median direct cost was ETB 79,248.02 (US $2,881.75; IQR 890.7 to 3,576.7). Moreover, 45.3% of the patients reported that they were either admitted or given medication at JUMC or nearby health facility before their current admissions.CONCLUSION: These findings indicate that most cases of bacterial meningitis were treated only empirically, and the cost of the treatment was high, especially for resource-limited countries like Ethiopia. To minimize the burden of meningitis and avoid unnecessary hospitalizations, the availability of diagnostic techniques is vitally important.

Clinical application value of metagenomic next-generation sequencing in the diagnosis of central nervous system infections

“…Central nervous system infections impose a heavy financial and mental burden on patients due to the risk of severe neurological sequelae and have a high mortality rate ( Acuña et al, 2022 ; Chala et al, 2022 ). In the study, the median cost of hospitalization for patients with CNS infections was $20,918.99 (8472.6; 31721.6), and the maximum cost of hospitalization was $151,792.8.…”